Cencora Inc
NYSE:COR
Intrinsic Value
Cencora, Inc. sources and distributes pharmaceutical products. [ Read More ]
The intrinsic value of one COR stock under the Base Case scenario is 408.15 USD. Compared to the current market price of 239.13 USD, Cencora Inc is Undervalued by 41%.
Valuation Backtest
Cencora Inc
Run backtest to discover the historical profit from buying and selling COR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Cencora Inc
Current Assets | 44.9B |
Cash & Short-Term Investments | 2.9B |
Receivables | 22.8B |
Other Current Assets | 19.1B |
Non-Current Assets | 19.8B |
PP&E | 2.1B |
Intangibles | 14B |
Other Non-Current Assets | 3.7B |
Current Liabilities | 50.8B |
Accounts Payable | 47.7B |
Accrued Liabilities | 2.4B |
Other Current Liabilities | 592.8m |
Non-Current Liabilities | 13B |
Long-Term Debt | 4.2B |
Other Non-Current Liabilities | 8.8B |
Earnings Waterfall
Cencora Inc
Revenue
|
271.6B
USD
|
Cost of Revenue
|
-262.4B
USD
|
Gross Profit
|
9.1B
USD
|
Operating Expenses
|
-6.5B
USD
|
Operating Income
|
2.7B
USD
|
Other Expenses
|
-797.9m
USD
|
Net Income
|
1.9B
USD
|
Free Cash Flow Analysis
Cencora Inc
What is Free Cash Flow?
COR Profitability Score
Profitability Due Diligence
Cencora Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Cencora Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
COR Solvency Score
Solvency Due Diligence
Cencora Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Cencora Inc's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
COR Price Targets Summary
Cencora Inc
According to Wall Street analysts, the average 1-year price target for COR is 259.59 USD with a low forecast of 226.24 USD and a high forecast of 288.75 USD.
Ownership
COR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
COR Price
Cencora Inc
Average Annual Return | 25.47% |
Standard Deviation of Annual Returns | 10.23% |
Max Drawdown | -5% |
Market Capitalization | 47.7B USD |
Shares Outstanding | 199 461 864 |
Percentage of Shares Shorted | 3.61% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Contact
IPO
Employees
Officers
The intrinsic value of one COR stock under the Base Case scenario is 408.15 USD.
Compared to the current market price of 239.13 USD, Cencora Inc is Undervalued by 41%.